272 related articles for article (PubMed ID: 27693232)
1. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
Shashi V; Pena LD; Kim K; Burton B; Hempel M; Schoch K; Walkiewicz M; McLaughlin HM; Cho M; Stong N; Hickey SE; Shuss CM; ; Freemark MS; Bellet JS; Keels MA; Bonner MJ; El-Dairi M; Butler M; Kranz PG; Stumpel CT; Klinkenberg S; Oberndorff K; Alawi M; Santer R; Petrovski S; Kuismin O; Korpi-Heikkilä S; Pietilainen O; Aarno P; Kurki MI; Hoischen A; Need AC; Goldstein DB; Kortüm F
Am J Hum Genet; 2016 Oct; 99(4):991-999. PubMed ID: 27693232
[TBL] [Abstract][Full Text] [Related]
2. Bainbridge-Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition.
Kuechler A; Czeschik JC; Graf E; Grasshoff U; Hüffmeier U; Busa T; Beck-Woedl S; Faivre L; Rivière JB; Bader I; Koch J; Reis A; Hehr U; Rittinger O; Sperl W; Haack TB; Wieland T; Engels H; Prokisch H; Strom TM; Lüdecke HJ; Wieczorek D
Eur J Hum Genet; 2017 Feb; 25(2):183-191. PubMed ID: 27901041
[TBL] [Abstract][Full Text] [Related]
3. Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literature.
Cuddapah VA; Dubbs HA; Adang L; Kugler SL; McCormick EM; Zolkipli-Cunningham Z; Ortiz-González XR; McCormack S; Zackai E; Licht DJ; Falk MJ; Marsh ED
Am J Med Genet A; 2021 Jun; 185(6):1700-1711. PubMed ID: 33751773
[TBL] [Abstract][Full Text] [Related]
4. Identification of a de novo variant in the ASXL2 gene related to Shashi-Pena syndrome.
Zheng Y; Yang L; Niu M; Zhao S; Liang L; Wu Y; Li T; Yang F; Yang Z; Wang Y; Wang D
Mol Genet Genomic Med; 2023 Nov; 11(11):e2251. PubMed ID: 37493007
[TBL] [Abstract][Full Text] [Related]
5. Delineating the phenotypic spectrum of Bainbridge-Ropers syndrome: 12 new patients with
Balasubramanian M; Willoughby J; Fry AE; Weber A; Firth HV; Deshpande C; Berg JN; Chandler K; Metcalfe KA; Lam W; Pilz DT; Tomkins S
J Med Genet; 2017 Aug; 54(8):537-543. PubMed ID: 28100473
[TBL] [Abstract][Full Text] [Related]
6. A newborn with a pathogenic variant in ASXL2 expanding the phenotype of SHAPNS: a case report and literature review.
Yuan M; Shan Y; Xu F; Yang L; Sun C; Cheng R; Wu B; Zhang Z; Cao Y; Zhang R; Zhou W; Cheng G; Hu L
Transl Pediatr; 2023 Jan; 12(1):86-96. PubMed ID: 36798937
[TBL] [Abstract][Full Text] [Related]
7. Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3.
Schirwani S; Albaba S; Carere DA; Guillen Sacoto MJ; Milan Zamora F; Si Y; Rabin R; Pappas J; Renaud DL; Hauser N; Reid E; Blanchet P; Foulds N; Dixit A; Fisher R; Armstrong R; Isidor B; Cogne B; Schrier Vergano S; Demirdas S; Dykzeul N; Cohen JS; Grand K; Morel D; Slavotinek A; Albassam HF; Naik S; Dean J; Ragge N; Costa C; Tedesco MG; Harrison RE; Bouman A; Palen E; Challman TD; Willemsen MH; Vogt J; Cunniff C; Bergstrom K; Walia JS; Bruel AL; Kini U; Alkuraya FS; Slegesky V; Meeks N; Girotto P; Johnson D; ; Newbury-Ecob R; Ockeloen CW; Prontera P; Lynch SA; Li D; Graham JM; Pierson TM; Balasubramanian M
Am J Med Genet A; 2021 Nov; 185(11):3446-3458. PubMed ID: 34436830
[TBL] [Abstract][Full Text] [Related]
8. Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome.
Hori I; Miya F; Ohashi K; Negishi Y; Hattori A; Ando N; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Saitoh S
Am J Med Genet A; 2016 Jul; 170(7):1863-7. PubMed ID: 27075689
[TBL] [Abstract][Full Text] [Related]
9. [Bainbridge-Ropers syndrome with ASXL3 gene variation in a child and literature review].
Zhang R; He XH; Lin HY; Yang XH
Zhonghua Er Ke Za Zhi; 2018 Feb; 56(2):138-141. PubMed ID: 29429203
[No Abstract] [Full Text] [Related]
10. A de novo nonsense mutation in
Koboldt DC; Mihalic Mosher T; Kelly BJ; Sites E; Bartholomew D; Hickey SE; McBride K; Wilson RK; White P
Cold Spring Harb Mol Case Stud; 2018 Jun; 4(3):. PubMed ID: 29305346
[TBL] [Abstract][Full Text] [Related]
11. Further expanding the clinical phenotype in Bainbridge-Ropers syndrome and dissecting genotype-phenotype correlation in the ASXL3 mutational cluster regions.
Yu KP; Luk HM; Fung JLF; Chung BH; Lo IF
Eur J Med Genet; 2021 Jan; 64(1):104107. PubMed ID: 33242595
[TBL] [Abstract][Full Text] [Related]
12. Modeling Bainbridge-Ropers Syndrome in
Lichtig H; Artamonov A; Polevoy H; Reid CD; Bielas SL; Frank D
Front Physiol; 2020; 11():75. PubMed ID: 32132929
[TBL] [Abstract][Full Text] [Related]
13. De novo nonsense variant in ASXL3 in a Chinese girl causing Bainbridge-Ropers syndrome: A case report and review of literature.
Wang Q; Zhang J; Jiang N; Xie J; Yang J; Zhao X
Mol Genet Genomic Med; 2022 May; 10(5):e1924. PubMed ID: 35276034
[TBL] [Abstract][Full Text] [Related]
14. De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge-Ropers syndrome.
Srivastava A; Ritesh KC; Tsan YC; Liao R; Su F; Cao X; Hannibal MC; Keegan CE; Chinnaiyan AM; Martin DM; Bielas SL
Hum Mol Genet; 2016 Feb; 25(3):597-608. PubMed ID: 26647312
[TBL] [Abstract][Full Text] [Related]
15. De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome.
Bainbridge MN; Hu H; Muzny DM; Musante L; Lupski JR; Graham BH; Chen W; Gripp KW; Jenny K; Wienker TF; Yang Y; Sutton VR; Gibbs RA; Ropers HH
Genome Med; 2013; 5(2):11. PubMed ID: 23383720
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
[TBL] [Abstract][Full Text] [Related]
17. Case report : a novel ASXL3 gene variant in a Sudanese boy.
Wu K; Cong Y
BMC Pediatr; 2021 Dec; 21(1):557. PubMed ID: 34886823
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes.
Awamleh Z; Chater-Diehl E; Choufani S; Wei E; Kianmahd RR; Yu A; Chad L; Costain G; Tan WH; Scherer SW; Arboleda VA; Russell BE; Weksberg R
Eur J Hum Genet; 2022 Jun; 30(6):695-702. PubMed ID: 35361921
[TBL] [Abstract][Full Text] [Related]
19. ASXL3-related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism.
Woods E; Holmes N; Albaba S; Evans IR; Balasubramanian M
Clin Genet; 2024 May; 105(5):470-487. PubMed ID: 38420660
[TBL] [Abstract][Full Text] [Related]
20. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
